Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125658642 | 12565864 | 2 | F | 20160610 | 20160726 | 20160718 | 20160801 | EXP | PHJP2016JP019955 | NOVARTIS | 68.00 | YR | F | Y | 0.00000 | 20160801 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125658642 | 12565864 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 200 TO 800 MG, UNK | 22068 | 800 | MG | CAPSULE | |||||||
| 125658642 | 12565864 | 2 | C | AMLODIN | AMLODIPINE BESYLATE | 1 | Oral | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125658642 | 12565864 | 1 | Chronic myeloid leukaemia |
| 125658642 | 12565864 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125658642 | 12565864 | HO |
| 125658642 | 12565864 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125658642 | 12565864 | Cerebral infarction | |
| 125658642 | 12565864 | Cerebral venous thrombosis | |
| 125658642 | 12565864 | Headache |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125658642 | 12565864 | 1 | 201407 | 0 |